Please use this identifier to cite or link to this item:
Title: The ASXL1 mutation p.Gly646Trpfs*12 found in a Turkish boy with Bohring-Opitz syndrome
Author: Urreizti, Roser
Gürsoy, Semra
Castilla-Vallmanya, Laura
Cunill, Guillem
Rabionet Janssen, Raquel
Erçal, Derya
Grinberg Vaisman, Daniel Raúl
Balcells Comas, Susana
Keywords: Mutació (Biologia)
Genètica humana
Mutation (Biology)
Human genetics
Issue Date: 10-Jun-2018
Publisher: John Wiley & Sons
Abstract: Bohring‐Opitz syndrome (BOS, MIM #605039) is a rare and severe disease characterized mainly by intrauterine growth retardation, feeding difficulties, severe to profound developmental delay, nonspecific brain abnormalities, microcephaly, flexion at the elbows with ulnar deviation and flexion of the wrists and metacarpophalangeal joints (known as BOS posture) and distinctive facial features.1 Heterozygous ASXL1 truncating mutations have been identified as the main cause of BOS.1, 2 A recent publication 3 called the attention to the fact that mutations associated with BOS are also present in the ExAC (Exome Aggregation Consortium) database.4 As ASXL1 is one of the genes most commonly mutated during hematopoietic clonal expansion of cells, the authors hypothesized that the presence of this mutation in public databases could be due to somatic mosaicism, and they could confirm the hypothesis by manual examination of the ExAC WES reads.
Note: Reproducció del document publicat a:
It is part of: Clinical Case Reports, 2018, vol. 6, num. 8, p. 1452-1456
Related resource:
ISSN: 2050-0904
Appears in Collections:Articles publicats en revistes (Genètica, Microbiologia i Estadística)

Files in This Item:
File Description SizeFormat 
680190.pdf360.02 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons